Harvard Bioscience Inc HBIO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
Harvard Bioscience Announces Creation of Scientific Advisory Board
Harvard Bioscience Announces Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $8.46
- Day Range
- $8.11–8.35
- 52-Week Range
- $4.00–9.10
- Bid/Ask
- $8.10 / $8.46
- Shares Outstanding
- 4.55M
- Market Cap
- $37.54M
- Volume/Avg
- 1,674 / 20,347
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 339
Valuation
Metric | HBIO |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.19 |
Price/Sales | 0.43 |
Price/Cash Flow | — |
Price/Earnings
HBIO
Financial Strength
Metric | HBIO |
|---|---|
Quick Ratio | 0.85 |
Current Ratio | 1.87 |
Interest Coverage | −0.54 |
Quick Ratio
HBIO
Profitability
Metric | HBIO |
|---|---|
Return on Assets (Normalized) | −2.97% |
Return on Equity (Normalized) | −19.11% |
Return on Invested Capital (Normalized) | 7.92% |
Return on Assets
HBIO
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|c?J!jKt | LOCK|^$# | $166B | |||
| Becton Dickinson & Co BDX | LOCK|%<? | LOCK|F?%&p | $58B | |||
| Alcon Inc ALC | LOCK|q##R!V | LOCK|BZCRm | $37B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|FvRhw$ | LOCK|CKQzC | $35B | |||
| ResMed Inc RMD | LOCK|^YwMcZk> | LOCK|!P?%P | $34B | |||
| West Pharmaceutical Services Inc WST | LOCK|wYX<h%h | LOCK|y# | $27B | |||
| Solventum Corp SOLV | LOCK|>J%JB>% | LOCK|F@ | $15B | |||
| Baxter International Inc BAX | LOCK|<G | LOCK|QFxZX | $13B | |||
| The Cooper Companies Inc COO | LOCK|ppSl$m% | LOCK|$m>% | $12B | |||
| Align Technology Inc ALGN | LOCK|B<s$Qh@ | LOCK|!s^!S | $11B |
United States